CTRI/2017/05/008651招募中未知
EGFR Mutation status in locally advanced NSCLC patients treated with Definitive Radiotherapy
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All patients with locally advanced Non-small cell lung cancer treated with radical intent with radiotherapy or chemo-radiotherapy. All patients should have biopsy to do EGFR mutation analysis
排除标准
- •Patients without an available biopsy.
研究者
相似试验
尚未招募
不适用
Clinical Outcome of Epidermal Growth Factor Receptor mutated (EGFR+) Non-small cell lung cancer (NSCLC) patients with first-line tyrosine kinase inhibitors (TKI) resistance on Osimertinib (CONTROL)metastatic EGFR mutated non small cell lung cancerAcquired resistance to first line EGFR inhibitorACTRN12617000993392Medical Oncology Department, Liverpool Hospital66
Unknown
不适用
A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation StatusNSCLCNCT01100827National University Hospital, Singapore
招募中
不适用
The continuous evaluation of EGFR mutation in EGFR-mutation positive lung cancer patients during EGFR TKI treatmentnon-small cell lung cancerJPRN-UMIN000037232Advanced Cancer Translational Research Institute100
Unknown
不适用
cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia ChinaNonsmall Cell Lung CancerAdenocarcinomaNCT02980536Berry Genomics Co., Ltd.129
已完成
不适用
An observational study of EGFR mutation status by circulating tumor DNA during the osimertinib treatment of lung cancer harboring EGFR activating and T790M mutations.lung CancerJPRN-UMIN000025278Miyagi Cancer Center60